News
FLGT
19.84
-0.75%
-0.15
Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?
NASDAQ · 3d ago
Weekly Report: what happened at FLGT last week (0930-1004)?
Weekly Report · 4d ago
Weekly Report: what happened at FLGT last week (0923-0927)?
Weekly Report · 09/30 10:48
Fulgent Genetics: An NCAV Pick With Profit And Growth Potential
Seeking Alpha · 09/25 15:32
Weekly Report: what happened at FLGT last week (0916-0920)?
Weekly Report · 09/23 10:48
Weekly Report: what happened at FLGT last week (0909-0913)?
Weekly Report · 09/16 10:40
OraSure Technologies: Nursing A COVID-19 Hangover
Seeking Alpha · 09/10 20:55
Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst
Seeking Alpha · 09/09 16:05
Weekly Report: what happened at FLGT last week (0902-0906)?
Weekly Report · 09/09 10:48
Weekly Report: what happened at FLGT last week (0826-0830)?
Weekly Report · 09/02 10:51
Weekly Report: what happened at FLGT last week (0819-0823)?
Weekly Report · 08/26 10:49
Weekly Report: what happened at FLGT last week (0812-0816)?
Weekly Report · 08/19 10:39
Fulgent Genetics (FLGT) Upgraded to Buy: What Does It Mean for the Stock?
NASDAQ · 08/13 16:00
How Much Upside is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22%
NASDAQ · 08/13 13:55
Weekly Report: what happened at FLGT last week (0805-0809)?
Weekly Report · 08/12 10:41
FULGENT GENETICS INC <FLGT.O>: PIPER SANDLER RAISES TARGET PRICE TO $26 FROM $25
Reuters · 08/05 14:00
Weekly Report: what happened at FLGT last week (0729-0802)?
Weekly Report · 08/05 10:49
Fulgent Genetics, Inc. Reports Financial Results for the Quarter Ended June 30, 2024
Press release · 08/02 12:17
Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates
NASDAQ · 08/02 12:15
Fulgent Genetics Releases Updated Investor Presentation
TipRanks · 08/02 11:27
More
Webull provides a variety of real-time FLGT stock news. You can receive the latest news about Fulgent Genetics through multiple platforms. This information may help you make smarter investment decisions.
About FLGT
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.